ES2056378T3 - Procedimiento de extraccion. - Google Patents

Procedimiento de extraccion.

Info

Publication number
ES2056378T3
ES2056378T3 ES90304029T ES90304029T ES2056378T3 ES 2056378 T3 ES2056378 T3 ES 2056378T3 ES 90304029 T ES90304029 T ES 90304029T ES 90304029 T ES90304029 T ES 90304029T ES 2056378 T3 ES2056378 T3 ES 2056378T3
Authority
ES
Spain
Prior art keywords
bacteria
extraction
extraction procedure
chapso
solubilised
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90304029T
Other languages
English (en)
Inventor
Ian William Davidson
Paul Sheard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unilever NV
Original Assignee
Unilever NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898908548A external-priority patent/GB8908548D0/en
Priority claimed from GB909004845A external-priority patent/GB9004845D0/en
Application filed by Unilever NV filed Critical Unilever NV
Application granted granted Critical
Publication of ES2056378T3 publication Critical patent/ES2056378T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56927—Chlamydia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/118—Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/871—Neisseria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

LA EXTRACCION MEJORADA DE ANTIGENOS SOLUBILIZADOS SE OBTIENE DE BACTERIAS COMO POR EJEMPLO CHLAMYDIA Y NEISSERIA MEDIANTE EL USO DE UN TAMPON QUE CONTIENE UN AGENTE ACTIVO DE SUPERFICIE ZWITTERIONICA, ESPECIALMENTE CHAPS O CHAPSO, EN AUSENCIA DE CATIONES DIVALENTES. LA EXTRACCION SE REALIZA A TEMPERATURA ELEVADA, Y PROPORCIONA UNA MUESTRA UTIL EN ANALISIS PARA DETECTAR LA PRESENCIA DE LA BACTERIA.
ES90304029T 1989-04-14 1990-04-12 Procedimiento de extraccion. Expired - Lifetime ES2056378T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898908548A GB8908548D0 (en) 1989-04-14 1989-04-14 Extraction procedure
GB909004845A GB9004845D0 (en) 1990-03-05 1990-03-05 Extraction procedure

Publications (1)

Publication Number Publication Date
ES2056378T3 true ES2056378T3 (es) 1994-10-01

Family

ID=26295225

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90304029T Expired - Lifetime ES2056378T3 (es) 1989-04-14 1990-04-12 Procedimiento de extraccion.

Country Status (8)

Country Link
US (1) US5387511A (es)
EP (1) EP0392865B1 (es)
JP (1) JP2516841B2 (es)
AT (1) ATE108557T1 (es)
AU (1) AU638453B2 (es)
DE (1) DE69010545T2 (es)
ES (1) ES2056378T3 (es)
WO (1) WO1990013032A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE904258A1 (en) * 1990-03-01 1991-09-11 Becton Dickinson Co Detection of chlamydia by flow-through assay
CA2048302A1 (en) * 1990-08-15 1992-02-16 Victoria P. Meucci Solubilization reagent for biological test samples
DK0624376T3 (da) 1993-05-13 2000-07-24 American Cyanamid Co Fremstilling og anvendelse af LOS-udtømte ydre membranproteiner af gram-negative cocci
US6121427A (en) * 1994-10-24 2000-09-19 Connaught Laboratories Limited Major outer membrane protein CD of branhamella
US5773234A (en) * 1995-08-07 1998-06-30 Quidel Corporation Method and device for chlamydia detection
DE69607095T2 (de) * 1995-09-14 2000-11-02 Unilever N.V., Rotterdam Test für lipopolysaccharide Antigene
EP0763738A1 (en) * 1995-09-14 1997-03-19 Unipath Limited Assays for Chlamydia in diluted urine samples
US5840585A (en) 1996-09-17 1998-11-24 Baylor College Of Medicine Rh blood group antigen compositions and methods of use
DE19756782A1 (de) 1997-12-19 1999-06-24 Dade Behring Marburg Gmbh Nachweis und Bestimmung festphasenassoziierter Faktoren
CA2906593C (en) 2013-03-15 2022-11-15 Ansun Biopharma, Inc. Method of protein purification

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD242716A3 (de) * 1981-08-28 1987-02-11 Adw Der Ddr Inst F Chem Techno Verfahren zur herstellung von gereinigten antigenen bzw. biopraeparaten
GB8427006D0 (en) * 1984-10-25 1984-11-28 Iq Bio Ltd Determination of chlamydia trachomatis
US4707543A (en) * 1985-09-17 1987-11-17 The United States Of America As Represented By The Secretary Of The Army Process for the preparation of detoxified polysaccharide-outer membrane protein complexes, and their use as antibacterial vaccines
US4959303A (en) * 1987-12-21 1990-09-25 Syntex (U.S.A.) Inc. Assay for antigens by binding immune complexes to solid supports free of protein and non-ionic binders
US4916057A (en) * 1988-02-29 1990-04-10 Kallestad Diagnostics, Inc. Chlamydia assay employing base treatment
DE3809796A1 (de) * 1988-03-23 1989-10-05 Wolfgang Prof Dr Med Bredt Verfahren zum reinigen eines 168 kd-proteins von mycoplasma pneumoniae

Also Published As

Publication number Publication date
EP0392865B1 (en) 1994-07-13
AU5437290A (en) 1990-11-16
DE69010545T2 (de) 1994-11-10
JP2516841B2 (ja) 1996-07-24
DE69010545D1 (de) 1994-08-18
EP0392865A1 (en) 1990-10-17
JPH03505132A (ja) 1991-11-07
AU638453B2 (en) 1993-07-01
ATE108557T1 (de) 1994-07-15
US5387511A (en) 1995-02-07
WO1990013032A1 (en) 1990-11-01

Similar Documents

Publication Publication Date Title
ATE183513T1 (de) Herstellung von antikörperfragmenten
NO920161L (no) Stabile vaksineblandinger inneholdende interleukiner
ES2056378T3 (es) Procedimiento de extraccion.
DE69122240D1 (de) Antigen-wirkende proteine von borrelia burgdorferi
IT9048221A0 (it) Procedimento e dispositivo per la adduzione di bottiglie oppure similari
MX9101907A (es) Proceso para la eliminacion de trialquil arsinas de fluidos que las contienen
AU525403B2 (en) Purified antigen
BR8902008A (pt) Composicao de limpeza,liquida,substancialmente nao aquosa,produto de limpeza e processos de limpeza de uma superficie e de tecidos ou de um artigo
DK0484438T3 (da) Biologisk præparat og dets anvendelse
ATE161955T1 (de) Elektrochemilumineszenzverfahren
SE8302959L (sv) Anordning vid ett med visningsyta forsett ljuspaverkbart visningsarrangemang jemte framstellningsforfarande for sagda anordning
IT7950319A0 (it) Procedimento e composizione di colorazione e di analisi per la determinazione di batteri in fluidi
IT9047636A1 (it) Apparecchiatura e procedimento per la prova di sincronizzatori per cambi di velocita'.
AU1994788A (en) Method for the diagnosis of infections with detection of lipopolysaccharide antigens
FR2662378B1 (fr) Appareil de nettoyage automatique de surfaces vitrees ou autres.
ES2056844T3 (es) Antigeno de treponema hyodysenteriae y sus usos.
FI922710A0 (fi) Eliminering av aktiverade lymfocyter.
SE8704114D0 (sv) Monoclonal antibody, a process for its preparation and the use thereof
DK0570682T3 (da) Syntetiske lipid-A-glycoconjugat-antigener til anvendelse i vacciner
DK0774119T3 (da) Oligomere bæremolekyler med på defineret måde indföjede markeringsgrupper og haptener
IT219499Z2 (it) Dispositivo contenitore per il trattamento di campioni biologici e similari
DE59102285D1 (de) Verfahren zur dekontaminierung von schadstoffbelastetem, losem, stückigem gut.
BR9707667A (pt) Complexos imunogênicos na forma de iscoms.
IT8745214A0 (it) Contenitore flessibile caratterizzato dal suo particolare dispositivo di chiusura per la confezione di prodotti vari
IT1163645B (it) Dispositivo per l'esecuzione di esami mircobiologici colturali, in particolare esami batteriologici e/o micologici

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 392865

Country of ref document: ES